Sarah Fakih | Vice President-Corporate Communications and Investor Relations |
Franz-Werner Haas | Chief Executive Officer |
Klaus Edvardsen | Chief Development Officer |
Pierre Kemula | Chief Financial Officer |
Mariola Fotin-Mleczek | Chief Technology Officer |
Manos Mastorakis | Deutsche Bank |
Evan Wang | Guggenheim Securities |
Jonathan Miller | Evercore ISI |
Zhiqiang Shu | Berenberg |
Aspen Mori | Bank of America |
Thank you. Good morning, good afternoon, and welcome to our conference call. My name is Sarah Fakih and I’m the Vice President of Corporate Communications and Investor Relations at CureVac. Please let me introduce today’s speakers.
On the call with me from CureVac are Franz-Werner Haas, the Chief Executive Officer of CureVac; Klaus Edvardsen, our Chief Development Officer; and Pierre Kemula, Chief Financial Officer of CureVac.